Genmab AS (Denmark) Technical Analysis
GMAB Stock | DKK 1,479 4.50 0.30% |
As of the 26th of November, Genmab AS retains the Market Risk Adjusted Performance of (1.70), standard deviation of 1.46, and Risk Adjusted Performance of (0.16). Genmab AS technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Genmab AS Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Genmab, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GenmabGenmab |
Genmab AS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Genmab AS Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Genmab AS volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Genmab AS Trend Analysis
Use this graph to draw trend lines for Genmab AS. You can use it to identify possible trend reversals for Genmab AS as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Genmab AS price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Genmab AS Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Genmab AS applied against its price change over selected period. The best fit line has a slop of 5.91 , which may suggest that Genmab AS market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1321474.86, which is the sum of squared deviations for the predicted Genmab AS price change compared to its average price change.About Genmab AS Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Genmab AS on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Genmab AS based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Genmab AS price pattern first instead of the macroeconomic environment surrounding Genmab AS. By analyzing Genmab AS's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Genmab AS's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Genmab AS specific price patterns or momentum indicators. Please read more on our technical analysis page.
Genmab AS November 26, 2024 Technical Indicators
Most technical analysis of Genmab help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Genmab from various momentum indicators to cycle indicators. When you analyze Genmab charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.16) | |||
Market Risk Adjusted Performance | (1.70) | |||
Mean Deviation | 0.9827 | |||
Coefficient Of Variation | (463.66) | |||
Standard Deviation | 1.46 | |||
Variance | 2.13 | |||
Information Ratio | (0.30) | |||
Jensen Alpha | (0.35) | |||
Total Risk Alpha | (0.55) | |||
Treynor Ratio | (1.71) | |||
Maximum Drawdown | 8.81 | |||
Value At Risk | (2.83) | |||
Potential Upside | 1.53 | |||
Skewness | (0.63) | |||
Kurtosis | 3.44 |
Additional Information and Resources on Investing in Genmab Stock
When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.